New dosage form of montelukast approved by KFDA

Published: 2011-10-13 06:56:00

Updated: 2011-10-13 06:56:00

SK Chemicals said Tuesday that it has received the market authorization of montelukast ODF (oral disintegrating film) from the Korea Food and Drug Administration.

Montelukast is a leukotriene receptor antagonist (LTRA) used for the maintenance treatment of asthma and to relieve symptoms of sea...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK